Company intelligence / Profile preview

Haimen Pharma

Haimen, Jiangsu, China
Ownership
Private
Development stage
Other
01

Overview

Haimen Pharma, officially known as Haimen Jingxin Pharmaceutical Co., Ltd., is a major pharmaceutical manufacturing entity and a core subsidiary of Zhejiang Jingxin Pharmaceutical. Located in the Haimen District of Nantong, China, the company is a leading producer of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, particularly in the cardiovascular and central nervous system (CNS) therapeutic areas. Its key products include widely used medications such as Simvastatin, Sertraline, and various fluoroquinolone antibiotics. Haimen Pharma's facilities are built to international standards, holding certifications from the NMPA, FDA, and EU GMP, which enables it to serve as a significant supplier to global pharmaceutical markets. In addition to its own product line, the company offers comprehensive CDMO services, leveraging its expertise in complex chemical synthesis and large-scale production.

Therapeutic areas
PsychiatryCardiovascularInfectious Diseases
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on Haimen Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haimen Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call